Print

Scientific Information

 

Cost advantages of peritoneal dialysis over haemodialysis in the first year of therapy

Few studies have compared resource consumption and costs associated with haemodialysis (HD) and peritoneal dialysis (PD) access. Here we report results from a retrospective analysis titled ‘Cost analysis of haemodialysis and peritoneal dialysis access in incident dialysis patients’ comparing these treatments in the first year of therapy that may have important implications for policymakers.

To view the full article, click here.

New study on Online Haemodiafiltration substantiates existing evidence on patient survival

The new Catalonian High Volume Online Haemodiafiltration (OL-HDF) study shows that High Volume OL-HDF therapy improves patients’ survival rate. With a 30% reduction of all-cause mortality and 33% lower risk of cardiovascular mortality patients should benefit from High Volume Online HDF.

More

Scientific papers

Fresenius Medical Care offers summaries of current nephrology publications to medical professionals. Simply visit: www.fmc-ag.com/2408.htm

You can also receive more scientific information here: www.fmc-ag.com/2412.htm

BalANZ Trial

The formation of of glucose degradation products (GDPs) is pH dependant and arise during the sterilisation process and storage of peritoneal dialysis fluids.
Utilising a dual chambered bag allows the sterilisation of the glucose to be performed at a very low pH, thus greatly reducing the GDP formation.

Click here to find out more about this trial

Therapy guidelines/recommendations

Click on the links below to access a number of guidelines.

logo kdoqi

KDOQI

Logo ERA EBPG

ERBP/EBPG

Logo kdigo

KDIGO

By using a link, you will leave the Fresenius Medical Care Australia website. Fresenius Medical Care does not take any responsibility for the content of the linked websites.